MetaVia Research Development from 2010 to 2026

MTVA Stock   1.70  0.09  5.03%   
MetaVia's Research Development is increasing over the years with slightly volatile fluctuation. Research Development is expected to dwindle to about 12.9 M. From 2010 to 2026 MetaVia Research Development quarterly data regression line had arithmetic mean of  9,796,644 and r-squared of  0.44. View All Fundamentals
 
Research Development  
First Reported
2015-03-31
Previous Quarter
2.3 M
Current Value
1.9 M
Quarterly Volatility
3.4 M
 
Yuan Drop
 
Covid
 
Interest Hikes
Check MetaVia financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among MetaVia's main balance sheet or income statement drivers, such as Interest Expense of 0.0, Selling General Administrative of 6.3 M or Other Operating Expenses of 20.1 M, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 1.88. MetaVia financial statements analysis is a perfect complement when working with MetaVia Valuation or Volatility modules.
  
Build AI portfolio with MetaVia Stock
Check out the analysis of MetaVia Correlation against competitors.
For information on how to trade MetaVia Stock refer to our How to Trade MetaVia Stock guide.
Analyzing MetaVia's Research Development over time reveals critical patterns in financial health and operational efficiency. This metric helps investors evaluate trends, identify inflection points, and make informed decisions based on historical performance. Understanding how Research Development has evolved provides context for assessing MetaVia's current valuation and future prospects.

Latest MetaVia's Research Development Growth Pattern

Below is the plot of the Research Development of MetaVia over the last few years. It is MetaVia's Research Development historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in MetaVia's overall financial position and show how it may be relating to other accounts over time.
Research Development10 Years Trend
Slightly volatile
   Research Development   
       Timeline  

MetaVia Research Development Regression Statistics

Arithmetic Mean9,796,644
Geometric Mean2,335,010
Coefficient Of Variation93.01
Mean Deviation7,822,758
Median8,740,000
Standard Deviation9,111,596
Sample Variance83T
Range24.7M
R-Value0.66
Mean Square Error49.4T
R-Squared0.44
Significance0
Slope1,199,763
Total Sum of Squares1328.3T

MetaVia Research Development History

202612.9 M
202524.8 M
202421.5 M
20239.2 M
20222.8 M
20216.5 M
202021.9 M

About MetaVia Financial Statements

MetaVia stakeholders use historical fundamental indicators, such as MetaVia's Research Development, to determine how well the company is positioned to perform in the future. Although MetaVia investors may analyze each financial statement separately, they are all interrelated. For example, changes in MetaVia's assets and liabilities are reflected in the revenues and expenses on MetaVia's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in MetaVia. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Research Development24.8 M12.9 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether MetaVia offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of MetaVia's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Metavia Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Metavia Stock:
Check out the analysis of MetaVia Correlation against competitors.
For information on how to trade MetaVia Stock refer to our How to Trade MetaVia Stock guide.
You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of MetaVia. Expected growth trajectory for MetaVia significantly influences the price investors are willing to assign. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive MetaVia assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Earnings Share
(10.45)
Return On Assets
(0.58)
Return On Equity
(1.68)
Understanding MetaVia requires distinguishing between market price and book value, where the latter reflects MetaVia's accounting equity. The concept of intrinsic value - what MetaVia's is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Market sentiment, economic cycles, and investor behavior can push MetaVia's price substantially above or below its fundamental value.
Understanding that MetaVia's value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether MetaVia represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. In contrast, MetaVia's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.